Find stats on top websites
Major Markets
The Global Lyme Alliance (GLA) positions itself as a leading non-profit driving research, education, and patient support to conquer Lyme disease, serving as a trusted hub for advancements and advocacy.
Customer sentiment appears largely positive due to GLA's transparent financial practices, comprehensive patient support, and significant research funding, fostering trust among donors, patients, and healthcare professionals. The provision of free resources and expert connections further enhances their positive perception.
GLA's key value proposition lies in its significant investment in cutting-edge research to find better diagnostics and treatments for Lyme disease. Additionally, it provides vital patient support services and comprehensive educational resources for both the public and medical professionals.
Leading Lyme disease research funder.
Comprehensive patient support services.
Strong educational resources for public & pros.
Reliance on donations for funding.
Potential for limited reach to rural areas.
Navigating Lyme disease controversies.
Expand global research collaborations.
Leverage digital platforms for wider education.
Increase corporate partnerships for funding.
Competition for philanthropic dollars.
Misinformation regarding Lyme disease.
Healthcare policy changes impacting funding.
GLA primarily serves the US, with a significant but smaller presence in Canada, UK, Australia, and Germany, indicating a strong North American focus.
United States
90% market share
Canada
3% market share
United Kingdom
2% market share
Australia
1.5% market share
Germany
1% market share
25-65 years
Male • Female
United States • Canada • Europe
30-70 years
Male • Female
Global
28-65 years
Male • Female
Global
35-80 years
Male • Female
United States • Global
18-75 years
Male • Female
United States • Canada • Europe
Data shown in percentage (%) of usage across platforms
Sign up now and unleash the power of AI for your business growth